Home › Trial NCT00016172
ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma
- Trial IDNCT00016172
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorMemorial Sloan Kettering Cancer Center
- Enrollment—
- Start date2000-11
- ConditionsLymphoma · Small Intestine Cancer · Unspecified Adult Solid Tumor, Protocol Specific
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.